School of Medicine
Showing 7,801-7,850 of 12,897 Results
-
Varsha Mysore Athreya
Postdoctoral Scholar, Otolaryngology - Head & Neck Surgery
BioVarsha began her academic journey with a BS in Speech and Hearing from the All India Institute of Speech and Hearing (AIISH) in Mysuru, India. She earned her Master’s degree in Audiology in 2018, with a thesis focused on temporal processing and speech perception in noisy environments. She completed her doctoral degree in May 2024, working with Dr. Bharadwaj on age-related effects on temporal processing and speech perception, and with Dr. Heinz on the effects of peripheral hearing damage on cortical auditory responses. Currently, she is a postdoctoral scholar at Stanford University with Dr. Matthew Fitzgerald, where she is developing pipelines for handling large clinical datasets and applying machine learning to enhance clinical diagnosis and management.
-
David Myung, MD, PhD
Associate Professor of Ophthalmology and, by courtesy, of Chemical Engineering
Current Research and Scholarly InterestsNovel biomaterials to reconstruct the wounded cornea
Mesenchymal stem cell therapy for corneal and ocular surface regeneration
Engineered biomolecule therapies for promote corneal wound healing
Telemedicine in ophthalmology -
Urs Naber
Clinical Associate Professor, Pediatrics - Critical Care
BioDr. Naber is the medical director for the pediatric intensive care unit at California Pacific Medical Center. His research focuses on value based development of medical technology for every part of the patient care chain.
-
Helen Nadel
Clinical Professor, Radiology - Pediatric Radiology
Current Research and Scholarly InterestsClinical research and scholarly interests include topics in Pediatric Nuclear Medicine to include AI evaluation for scintigraphic quantitation, PET MR evaluation of optimized techniques for use in pediatric patient management
-
Ronjon Nag, PhD
Adjunct Professor, Genetics
BioRonjon Nag is an inventor, teacher and entrepreneur. He is an Adjunct Professor in Genetics at the Stanford School of Medicine, becoming a Stanford Distinguished Careers Institute Fellow in 2016. He teaches AI, Genes, Ethics, Longevity Science and Venture Capital. He is a founder and advisor/board member of multiple start-ups and President of the R42 Group, a venture capital firm which invests in, and creates, AI and Longevity companies. As an AI pioneer of smartphones and app stores, his companies have been sold to Apple, BlackBerry, and Motorola. More recently he has worked on the intersection of AI and Biology. He has been awarded the IET Mountbatten Medal by the Institution of Engineering and Technology, the 2021 IEEE-SCV Outstanding Engineer Award, the $1m Verizon Powerful Answers Award, the 2023 COGX AI Lifetime Achievement Award, the 2023 MIT Great Dome Award, and was the 2024 Inductee in the Silicon Valley Engineering Hall of Fame. Professor Nag has a Ph.D from Cambridge, an M.S from Massachusetts Institute of Technology and a B.Sc. from Birmingham in the UK. He has numerous interests in the intersection of AI and Healthcare including being CEO of Agemica.ai working on creating a vaccine for aging.
He has many firsts including:
Firsts:
• First laptop with speech recognition built-in (with Apricot, 1984)
• First selling cursive handwriting recognition (with Lexicus, 1991)
• First speech recognition phones (with Lexicus/Motorola, 1996)
• First large-vocabulary Chinese speech recognition (with Lexicus/Motorola, 1996)
• First Chinese predictive text system on a phone (Lexicus/Motorola, 1997)
• First predictive text systems in 40 languages on Motorola phones, (Lexicus/Motorola, 1997)
• First touch screen mobile phone with handwriting recognition (Lexicus/Motorola, 1999)
• First combined mobile search engine and directory (with Cellmania, 2000)
• First private label downloadable operator billable apps store (Cellmania, 2000)
• First BlackBerry Operator Billing apps store (Cellmania,2010)
• First Neural Network Artificial Intelligence System in the Cloud (Ersatz Labs, 2014)
• First Throwable 360 Ball Camera (Bounce Imaging, 2015)
• First Android powered smart light switch (Brightswitch 2017)
• First blood pressure watch with temperature and pulse oximetry add-ons for Back to Work Covid Kit (GTCardio 2019)
• First no code AI life sciences app store (Superbio.ai 2022)
• First proposal for an aging vaccine (Agemica 2023) -
Claude M. Nagamine, DVM, PhD
Associate Professor of Comparative Medicine
Current Research and Scholarly InterestsMouse models to study murine and human infectious diseases. These colloborative studies include dengue virus, zika virus, adeno-associated virus, coxsackie virus, enterovirus 71, enterohepatic helicobacters, campylobacters, and anaplasma.
-
Dhriti Nagar
Postdoctoral Scholar, Neonatal and Developmental Medicine
BioPremature birth is a leading cause of developmental and neuropsychiatric disorders in children. One of the factors causing these defects is lowered levels of available oxygen (hypoxia) in the newborn due to immature lungs. My research focuses on understanding the cellular and molecular mechanisms underlying hypoxia-induced developmental disorders of the nervous system due to preterm birth.
-
Himaja Nagireddy
Ph.D. Student in Health Policy, admitted Autumn 2025
BioHimaja Nagireddy (she/her) is a PhD student in Health Policy at Stanford. She previously served as a Program Manager at the Kennedy Krieger Institute, an affiliate of the Johns Hopkins School of Medicine, in Baltimore, MD.
Prior to this, Himaja served as the Deputy Associate Policy Director for First Lady Dr. Jill Biden at the White House, Briefings Manager for the Harris-Walz campaign, and Research Fellow at the CDC’s Agency for Toxic Substances and Disease Registry (ATSDR). She also served as the 11th Youth Observer to the UN from 2022-23. Himaja graduated with an MS in Environmental Epidemiology and a concentration in Infectious Disease Epidemiology from the Harvard T.H. Chan School of Public Health in 2022, and her bachelor’s degrees in Physiology and Neurobiology, Molecular and Cell Biology, and Sociology from the University of Connecticut in 2020. -
Seema Nagpal, MD
Clinical Professor, Adult Neurology
Clinical Professor (By courtesy), NeurosurgeryCurrent Research and Scholarly InterestsI'm a board certified neuro-oncologist who treats both primary brain tumors as well as metastatic disease to the brain and nervous system. My research concentrates on clinical trials for patients with late-stage central nervous system cancer. I have a special interest in leptomeningeal disease, a devastating complication of lung and breast cancers. I collaborate with Stanford scientists to detect this disease earlier, and with our breast and lung oncologists to improve outcomes for patients.
-
Hetanshi Naik
Associate Professor (Teaching) of Genetics
BioHetanshi Naik is an Associate Professor in the Department of Genetics and the Research Director of the MS Program in Human Genetics and Genetic Counseling. She is a board certified genetic counselor and clinical researcher with clinical expertise in the inborn errors of heme biosynthesis, the Porphyrias, lysosomal storage disorders (LSDs), and pharmacogenomics, and research expertise in clinical trials, patient reported outcomes (PROs), qualitative methods, and study design.
Her research interests include developing and evaluating PROs for genetic disorders and genomics, in particular assessing PROs as outcomes for clinical trials, pharmacogenomics implementation, and genetic counseling education and processes, as well as utilizing digital health technologies to improve clinical care, genetic counseling, patient reporting, trial efficacy, and outcomes. -
Priya Nair
Ph.D. Student in Bioengineering, admitted Autumn 2020
BioI received my Bachelor's degree in Biomedical Engineering with a minor in Industrial Design from Georgia Institute of Technology in 2020. During my time at Georgia Tech, I worked as an undergraduate researcher in Dr. Ajit Yoganathan's Cardiovascular Fluid Mechanics Lab. My project was focused on studying the contribution of foreign materials to thrombosis in transcatheter aortic valves using an in vitro flow loop. Beyond my research interests, I was also actively involved in the Society of Women Engineers, promoting outreach activities and creating mentorship opportunities for women in STEM.
-
Ramesh Nair
Director of Bioinformatics, SCGPM, Genetics
Current Role at StanfordDirector, Bioinformatics
Stanford Center for Genomics and Personalized Medicine (SCGPM)
Bioinformatics-as-a-Service (BaaS)
Genetics Bioinformatics Service Center (GBSC)
Diabetes Genomics Analysis Core (DGAC)
Stanford University School of Medicine -
Michitaka Nakano
Basic Life Research Scientist, Medicine - Med/Hematology
BioI am a MD/PhD postdoctoral fellow and medical oncologist with a long-standing interest in translational cancer research. My long-term goal is to be a lab-based physician-scientist and independent academic researcher, translating basic cancer research, and mentoring next-generation scientists. My thesis work in Japan focused on cancer stem cell equilibrium by uniquely applying organoid culture as a method to elucidate cancer stem cell dynamics, which was awarded in Japanese Cancer Association. Along with the development of the field represented by success in T cell checkpoint, my interest gradually shifted to immune oncology while I examined numerous numbers of cancer patients as a medical oncology fellow. My postdoctoral fellowship at Calvin Kuo Lab in Stanford (2019-present) focuses on tumor immune microenvironment. Kuo lab developed a unique 3D air-liquid interface (ALI) organoid system that cultures tumors while preserving their endogenous infiltrating immune cells (T,B ,NK, Myeloid cells). My postdoctoral work will prove the significance of organoids as a translational tool to discover tumor-immune interaction by novel checkpoint inhibitors for immune cells, which can be broadly applicable to basic cancer biology, precision medicine, therapeutics validation and biomarker discovery.
-
Hiromitsu (Hiro) Nakauchi
Professor of Genetics (Stem Cell)
Current Research and Scholarly InterestsTranslation of discoveries in basic research into practical medical applications
-
Yusuke Nakauchi, MD, PhD
Basic Life Research Scientist, Stem Cell Bio Regenerative Med Institute
BioMy research projects aim to investigate the biology of human leukemia. I believe my research will contribute to clarify the disease pathogenesis of leukemia and help identify the critical cells to target to both prevent the development of de novo leukemia and halt relapse.
-
Puja Nakrani
Affiliate,
BioAffiliate, Stanford Neurosurgery
